1h Free Analyst Time
The human growth hormone market is forecasted to grow by USD 949.1 million during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the human growth hormone market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by development of long-acting and needle-free deliveries to improve adherence, fda approval of human growth hormone replacement therapy for new indications, and strong pipeline of human growth hormones.
The human growth hormone market is segmented as below:
By Application
- Growth hormone deficiency
- ISS
- Turner syndrome
- PWS
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the human growth hormone market covers the following areas:
- Human growth hormone market sizing
- Human growth hormone market forecast
- Human growth hormone market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The comapniespresents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global human growth hormone market: Abbott Laboratories, Aeterna Zentaris Inc., Anhui Anke Biotechnology Group Co. Ltd., Ascendis Pharma AS, F. Hoffmann La Roche Ltd., Ferring BV, Ipsen Pharma, LG Chem Ltd., Merck and Co. Inc., Novo Nordisk AS, Pfizer Inc., Sandoz Group AG, Teva Pharmaceutical Industries Ltd., Xeris Biopharma Holdings Inc., and Zhongshan Sinobioway Hygene Biomedicine Co. Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing incidence of growth disorders."
According to the report, one of the major drivers for this market is the development of long-acting and needle-free deliveries to improve adherence.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Aeterna Zentaris Inc.
- Anhui Anke Biotechnology Group Co. Ltd.
- Ascendis Pharma AS
- F. Hoffmann La Roche Ltd.
- Ferring BV
- Ipsen Pharma
- LG Chem Ltd.
- Merck and Co. Inc.
- Novo Nordisk AS
- Pfizer Inc.
- Sandoz Group AG
- Teva Pharmaceutical Industries Ltd.
- Xeris Biopharma Holdings Inc.
- Zhongshan Sinobioway Hygene Biomedicine Co. Ltd.
